HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

denopamine

structure given in first source
Also Known As:
(3,4-dimethoxyphenethylaminomethyl)-4-hydroxybenzyl alcohol; 1-(p-hydroxyphenyl)-2-((3,4-dimethoxyphenethyl)amino)ethanol; TA 064; TA-064; Benzenemethanol, alpha-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methyl)-4-hydroxy-, (R)-
Networked: 29 relevant articles (5 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ohya, N: 3 articles (07/2001 - 01/2001)
2. Nambu, Y: 3 articles (07/2001 - 01/2001)
3. Sakuma, T: 3 articles (07/2001 - 01/2001)
4. Toga, H: 3 articles (07/2001 - 01/2001)
5. Osanai, K: 3 articles (07/2001 - 01/2001)
6. Takahashi, K: 3 articles (07/2001 - 01/2001)
7. Ishigaki, M: 2 articles (07/2001 - 01/2001)
8. Tuchihara, C: 2 articles (07/2001 - 01/2001)
9. Matthay, M A: 2 articles (07/2001 - 01/2001)
10. Inoue, M: 2 articles (07/2001 - 02/2001)

Related Diseases

1. Heart Failure
2. Spasm (Spasms)
3. Dyspnea (Shortness of Breath)
4. Angina Pectoris
5. Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
02/01/1992 - "In 9 patients with dilated cardiomyopathy, the effects of beta 1-agonist were tested at the beginning of therapy (30 mg/day denopamine) and 6 months later. "
03/01/1987 - "In 18 patients with dilated cardiomyopathy (DCM), the effects of a new cardiotonic agent, TA-064, given in both consecutive and intermittent (3 days on, 11 days off) oral doses were studied for 3 months by echocardiography and endomyocardial biopsy. "
08/01/1985 - "We analyzed computer-assisted alterations of pressure-volume relationships serially and of indirect myocardial oxygen consumption (MVO2) estimations on line during TA-064 influence in 16 patients with congestive cardiomyopathy: left ventricular function was moderately decreased in seven patients (group A) and drastically decreased in nine (group B). "
12/01/1984 - "We analyzed computer-assisted alterations of pressure-volume relations serially and of MVO2 online (Bretschneider) during TA-064 influence in 16 patients with congestive cardiomyopathy: LV-function of 7 patients was only moderately decreased (group A) and in 9 patients massively (group B). "
05/01/1993 - "Three patients had ischemic heart disease, 13 had dilated cardiomyopathy, and three had valvular disease; 16 patients were in New York Heart Association class II, and three patients were in New York Heart Association class III. Symptom-limited exercise testing (ramp protocol) on a bicycle ergometer with gas exchange analysis was conducted 1 hour after oral administration of either 20 mg denopamine or placebo. "

Related Drugs and Biologics

1. Adrenergic Receptors (Adrenergic Receptor)
2. Adrenergic beta-Agonists (beta-Adrenergic Agonists)
3. denopamine
4. Adrenergic Agonists (Adrenergic Receptor Agonist)
5. Terbutaline (Brethaire)
6. Prazosin (Minipress)
7. Midodrine (Midon)
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
9. Streptozocin (Streptozotocin)
10. Pentobarbital (Nembutal)

Related Therapies and Procedures

1. Renal Dialysis (Hemodialysis)
2. Oral Administration